Bolt Biotherapeutics (BOLT) Income from Continuing Operations (2020 - 2025)
Historic Income from Continuing Operations for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to -$7.2 million.
- Bolt Biotherapeutics' Income from Continuing Operations rose 5238.53% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.8 million, marking a year-over-year increase of 3859.66%. This contributed to the annual value of -$67.8 million for FY2024, which is 202.9% up from last year.
- Latest data reveals that Bolt Biotherapeutics reported Income from Continuing Operations of -$7.2 million as of Q3 2025, which was up 5238.53% from -$8.6 million recorded in Q2 2025.
- In the past 5 years, Bolt Biotherapeutics' Income from Continuing Operations ranged from a high of -$7.2 million in Q3 2025 and a low of -$27.2 million during Q4 2021
- In the last 5 years, Bolt Biotherapeutics' Income from Continuing Operations had a median value of -$18.0 million in 2023 and averaged -$18.1 million.
- As far as peak fluctuations go, Bolt Biotherapeutics' Income from Continuing Operations plummeted by 11326.52% in 2021, and later surged by 5937.25% in 2025.
- Quarter analysis of 5 years shows Bolt Biotherapeutics' Income from Continuing Operations stood at -$27.2 million in 2021, then increased by 26.37% to -$20.0 million in 2022, then rose by 10.47% to -$17.9 million in 2023, then rose by 10.99% to -$15.9 million in 2024, then skyrocketed by 54.66% to -$7.2 million in 2025.
- Its last three reported values are -$7.2 million in Q3 2025, -$8.6 million for Q2 2025, and -$11.1 million during Q1 2025.